A siemens field service engineer (fse) was sent to the customer site.The fse found the reagent probe 1 alignment was off.The fse performed an alignment on probe 1 with no issues.The customer ran calibrations and quality controls with no issues.After the alignment on probe 1, lot 282 was calibrated with a new shipment of calibrator q lot cq74 and recovery returned to normal.It is unclear whether the probe alignment or the new calibrator resolved the issue.The cause for the discordant advia centaur xp psa results could be due to the probe alignment and/or shipping/handling of the original vials of calibrator q lot cq74.The instrument is performing within specification.No further evaluation of the device is required.The ifu states in the limitations section: "note: do not interpret levels of psa as absolute evidence of the presence or the absence of malignant disease.Before treatment, patients with confirmed prostate carcinoma frequently have levels of psa within the range observed in healthy individuals.Elevated levels of psa can be observed in patients with nonmalignant diseases.Measurements of psa should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation." mdr 1219913-2018-00005 was filed for the same event.
|